KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Aquestive Therapeutics (AQST) Receivables - Net (2017 - 2026)

Aquestive Therapeutics has reported Receivables - Net over the past 9 years, most recently at $17.8 million for Q4 2025.

  • For Q4 2025, Receivables - Net rose 141.87% year-over-year to $17.8 million; the TTM value through Dec 2025 reached $17.8 million, up 141.87%, while the annual FY2025 figure was $17.8 million, 141.87% up from the prior year.
  • Receivables - Net for Q4 2025 was $17.8 million at Aquestive Therapeutics, up from $11.8 million in the prior quarter.
  • Over five years, Receivables - Net peaked at $19.9 million in Q1 2022 and troughed at $4.7 million in Q4 2022.
  • A 5-year average of $10.8 million and a median of $9.9 million in 2023 define the central range for Receivables - Net.
  • Biggest five-year swings in Receivables - Net: plummeted 62.05% in 2023 and later surged 141.87% in 2025.
  • Year by year, Receivables - Net stood at $9.7 million in 2021, then crashed by 51.39% to $4.7 million in 2022, then surged by 80.08% to $8.5 million in 2023, then dropped by 13.3% to $7.3 million in 2024, then surged by 141.87% to $17.8 million in 2025.
  • Business Quant data shows Receivables - Net for AQST at $17.8 million in Q4 2025, $11.8 million in Q3 2025, and $9.7 million in Q2 2025.